Program Closure definition

Program Closure means to cease operation of a nursing program.
View Source
Program Closure means a member program that has: (i) issued a notice of closure or dissolution; (ii) entered into bankruptcy or insolvency; or (iii) excluding closures encountered in the normal course of business, ceased all operations for at least thirty (30) consecutive days without notifying Languages Canada and/or students whether the closed state of affairs is temporary. In case (iii), the member program will be presumed closed and this presumption may be reversed by representatives of the member program.
View Source
Program Closure. Any party wishing to close a Cross-Faculty program must convene a meeting of the Program Committee, relevant Deans’ offices and the Vice-▇▇▇▇▇▇▇ Academic. All program closure protocols must be followed: ▇▇▇▇://▇▇▇▇▇.▇▇▇▇.▇▇▇▇▇.▇▇/program-closure/
View Source

Examples of Program Closure in a sentence

  • When non- reappointment is based on reasons other than the Trainee’s performance or his/her compliance with the terms of this Agreement (WSU, Hospital or Program Closure, reduction or discontinuance) it shall be final and not subject to further appeal or review and shall not be grievable under WSU’s grievance procedure.

  • All policies, including those concerning Disruptive Behavior; Resident Evaluation, Promotion, and Discipline; Program Closure / Reductions; Resident Health (Impairment); Leaves of Absence (including vacation, parental, and sick leave as well as the effect of leave on program completion); Duty Hours; Moonlighting or any alternatively named policy discussing clinical experience, education, and limits placed on the resident’s schedule shall be provided to the Resident both in writing and electronically.

  • The Institutional Responsibility for Residency Program Closure or Reduction in Program Size Policy is under the tab entitled “Policies and Procedures” on Clinic’s Residency and Fellows Intranet website.

  • In the event of a closure or reduction in size of a training program, the policy provided in Article 24 of the CBA (Attachment 2) and policy # C-581, “Residency Program Closure and Downsizing” (Attachment 8), will be followed.

  • The policy can be found under the Institutional Policies header and is labeled as Program Closure and Reduction Policy.

  • In conjunction with the Program Closure Plan, MCC and MCA will develop a Post-Compact M&E Plan designed to observe the persistence of benefits created under the Compact.

  • In the event of a Permanent Reduction of Hours or Program Closure, non-probationary employees being laid off will receive seven (7) calendar days’ notice by personal contact, telephone call, or written communication prior to being laid off.

  • The GME Program Policies include, but are not limited to, the following: Equal Employment Opportunity; Promotion and Contracts; Academic Due Process; Leaves of Absence; Clinical and Educational Work Hours; Moonlighting; Program Closure or Reduction; Accommodations of Disabilities; and Harassment and Discrimination.

  • Other documents including but not limited to, the: Bank Agreement, Fiscal Agent Agreement, Fiscal Accountability Plan, Procurement Operations Manual, Procurement Plan, Program Procurement Guidelines, Implementing Entity Agreement(s), M&E Plan, Implementation Plan(s), Program Closure Plan and Work Plans for the relevant Project or Project Activity.

  • In the event that the number of House Officers in the Hospital’s program is reduced, or the Hospital’s training program is discontinued, the provisions of B I Deaconess Medical Center Policy Regarding Residency Program Closure or Position Reduction will apply.

Related to Program Closure

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Program Plan means the tobacco settlement program plan dated February 14, 2001, including exhibits to the program plan, submitted by the authority to the legislative council and the executive council, to provide the state with a secure and stable source of funding for the purposes designated by section 12E.3A and other provisions of this chapter.

  • Development Plans has the meaning set forth in Section 3.2.